Skip to content

CARDIO LOGIC

Active
Private limited companyfounded 201412 yrs activeLangehaagstraat 4, 1000 Brussel, BelgiumKBO/BCE: BE 0553.870.691
Summary

CARDIO LOGIC has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €306,005 and a net result of €185,884. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 19928 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).

Risk analysisWatch ReportCompare
CARDIO LOGICActiveChecked score 67/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
Size
€1.7mtotal assets 2024
Staff
1.7 FTE
Equity
€306,005
Profit
€185,884
Turnover not published (abridged schema)
Financial health
67 Healthy Checked score 2024
Bankruptcy chance 12 m
0.9%
Structure
Accounts 64 d overdue0 of 3 deeds read
Why 67- Figures for FY 2024 (filed 26-09-2025)- No establishment unit in the KBO+ Sector Human health activities (NACE 86)+ Size: total assets €1.7mShow the evidence

Checked score

Score 2024
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 39% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2023
Average
Solvency 44+10
equity 18.5% of total assets
Liquidity 45-5
short-term debt 29.2% · cash 5.4%
Profitability 83+9
return on assets 11.2%
Bankruptcy probability, 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%

About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,682 companies)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%▼ -2.2% vs 11-2024 01-2025: 0.3%▼ -0.7% vs 12-2024 02-2025: 0.3%▲ +2.3% vs 01-2025 03-2025: 0.4%▲ +16.7% vs 02-2025 04-2025: 0.4%▲ +2.5% vs 03-2025 05-2025: 0.4%▲ +10.2% vs 04-2025 06-2025: 0.5%▲ +13.9% vs 05-2025 07-2025: 0.6%▲ +22.9% vs 06-2025 08-2025: 0.8%▲ +37.5% vs 07-2025 09-2025: 1.0%▲ +24.7% vs 08-2025highest value 10-2025: 0.2%▼ -82.5% vs 09-2025 11-2025: 0.2%● 0.0% vs 10-2025 12-2025: 0.2%● 0.0% vs 11-2025 01-2026: 0.2%▼ -1.2% vs 12-2025lowest value 02-2026: 0.2%▲ +1.2% vs 01-2026 03-2026: 0.2%▲ +17.4% vs 02-2026 04-2026: 0.2%▼ -11.4% vs 03-2026 05-2026: 0.2%▲ +8.9% vs 04-2026 06-2026: 0.2%▲ +10.3% vs 05-2026 07-2026: 0.3%▲ +30.7% vs 06-2026 08-2026: 0.5%▲ +77.6% vs 07-2026 09-2026: 0.6%▲ +23.8% vs 08-2026 10-2026: 0.9%▲ +40.9% vs 09-2026
  • Sector Human health activities (NACE 86) lowers the probability
  • Figures for FY 2024 (filed 26-09-2025) raises the probability
  • Size: total assets €1.7m lowers the probability for this profile
  • No establishment unit in the KBO raises the probability
Credit up to €20,000 at 30 days acceptable
Liquidity tight (current ratio 1.39 against 0.7 in 2023; short-term debt: 29.2% and cash: 5.4% of total assets), and 81.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 19%, liquidity 13%, profitability 31%, growth against the median 94%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Figures for FY 2024 (filed 26-09-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: total assets €1.7m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · No establishment unit in the KBO
In the bankruptcy model this factor raises the probability.
KBO · seat and establishments
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 19928 sector peers (2024).
NBB · sector comparison
Position among 19928 sector peers
Solvency
better than 14%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year €306,005
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-09-2025, 54 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
54 d late
2023
76 d late
2022
68 d late
2021
92 d late
2020
135 d late
2019
211 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 106 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · micro…
  2. Highest result since 2018net €185,884 ▲222%
  3. Equity above €200,000Eq €306,005 ▲155%

Key points

  • Positive: Result rose in 2024from €57,661 to €185,884 ▲ 222% View
  • Caution: Among the weakest 15% on solvencysector median 67.5% · 19,928 companies 18.5% View
  • Caution: Accounts not fileddeadline was 31-07-2026 64 d late View

By topic

Financials

Fiscal year
2024
Total assets
€1.7m
Profit
€185,884
Solvency
18.5%
Total assets▲ 22.2%
Net result
20182024
Go to Financials

Timeline

Events
15
Since
2017
  1. 23-09-2025Annual accounts filed
  2. 31-12-2024Highest result since 2018
  3. 31-12-2024Equity above €200,000
Go to Timeline

Company details

Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
17-06-2014
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure